News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Quintiles, Inc. (QTRN) Named Preferred Provider in Phase I Market Report



8/9/2013 9:39:58 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Quintiles is the preferred Phase I service provider and most frequently cited as the leading provider for complex studies, according to 119 pharmaceutical and biotechnology professionals surveyed in Industry Standard Research’s (ISR) 2013 Phase I Study Trends and Market Outlook Report. This announcement comes on the heels of Quintiles’ recognition as the industry leader and highest in service quality in Phase II/III clinical research in a separate ISR report released in May.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES